Jim Cassidy, Global Head of Translational Medicine ( Oncology), Hoffmann La-Roche, USA,Donald Bissett, Consultant in Clinical Oncology,, Aberdeen Royal Infirmary, Aberdeen, UK,Roy A. J. Spence OBE, Consultant Surgeon; Honorary Professor, Belfast Trust; Queen University, Belfast, University of Ulster, Northern Ireland, UK,Miranda Payne, Specialist Registrar in Medical Oncology, Oxford University Hospitals NHS Trust, UK,Gareth Morris-Stiff, Attending Surgeon; Associate Professor, Cleveland Clinic, Cleveland, Ohio; Lerner College of Medicine, Case Western Reserve University, USA
Jim Cassidy was previously Professor of Oncology at Aberdeen university (1994-2002), then CRUK Head of Oncology, Beatson Laboratories, Glasgow. He moved into pharma over 2 years ago to head early drug development.
Donald Bissett was schooled in Glasgow, and graduated from St Andrews University 1979 and University of Manchester 1982. Clinical experience in South Manchester Hospitals led to MRCP 1986, then commenced clinical oncology training in Nottingham and Glasgow, with FRCR 1989. Research Fellowship in the Department of Medical Oncology Beatson Institute, with MD and MSc in Clinical Pharmacology 1992. Senior lecturer in Clinical Oncology 1994, then Consultant in Clinical Oncology in Aberdeen 1995-2013 with particular interests in urological and thoracic malignancies.
|